Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.

<h4>Background and objective</h4>Accumulating evidence shows that long noncoding RNAs (lncRNAs) possess great potential in the diagnosis and prognosis of prostate cancer (PCa). Therefore, this study aimed to construct an lncRNA-based signature to more accurately predict the prognosis of...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng Zhang, Xiaodong Tan, Daoqiang Zhang, Qi Gong, Xuefeng Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249951&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850239809371504640
author Peng Zhang
Xiaodong Tan
Daoqiang Zhang
Qi Gong
Xuefeng Zhang
author_facet Peng Zhang
Xiaodong Tan
Daoqiang Zhang
Qi Gong
Xuefeng Zhang
author_sort Peng Zhang
collection DOAJ
description <h4>Background and objective</h4>Accumulating evidence shows that long noncoding RNAs (lncRNAs) possess great potential in the diagnosis and prognosis of prostate cancer (PCa). Therefore, this study aimed to construct an lncRNA-based signature to more accurately predict the prognosis of different PCa patients, so as to improve patient management and prognosis.<h4>Methods</h4>Through univariate and multivariate Cox regression analysis, this study constructed a 4 lncRNAs-based prognosis nomogram for the classification and prediction of survival risk in patients with PCa based on TCGA data. Then we used the data of TCGA and ICGC to verify the performance of our prediction model. The receiver operating characteristic curve was plotted for detecting and validating our prediction model sensitivity and specificity. In addition, Cox regression analysis was conducted to examine whether the signature's prediction ability was independent of additional clinicopathological variables. Possible biological functions for those prognostic lncRNAs were predicted on those 4 protein-coding genes (PCGs) related to lncRNAs.<h4>Results</h4>Four lncRNAs (HOXB-AS3, YEATS2-AS1, LINC01679, PRRT3-AS1) were extracted after COX regression analysis for classifying patients into high and low-risk groups by different OS rates. As suggested by ROC analysis, our proposed model showed high sensitivity and specificity. Independent prognostic capability of the model from other clinicopathological factors was indicated through further analysis. Based on functional enrichment, those action sites for prognostic lncRNAs were mostly located in the extracellular matrix and cell membrane, and their functions are mainly associated with the adhesion, activation and transport of the components across the extracellular matrix or cell membrane.<h4>Conclusion</h4>Our current study successfully identifies a novel candidate, which can provide more convincing evidence for prognosis in addition to the traditional clinicopathological indicators to predict the PCa survival, and laying the foundation for offering potentially novel therapeutic treatment. Additionally, this study sheds more lights on the PCa-related molecular mechanisms.
format Article
id doaj-art-17ebcdd489b84edfbbb2072799442c1a
institution OA Journals
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-17ebcdd489b84edfbbb2072799442c1a2025-08-20T02:01:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01165e024995110.1371/journal.pone.0249951Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.Peng ZhangXiaodong TanDaoqiang ZhangQi GongXuefeng Zhang<h4>Background and objective</h4>Accumulating evidence shows that long noncoding RNAs (lncRNAs) possess great potential in the diagnosis and prognosis of prostate cancer (PCa). Therefore, this study aimed to construct an lncRNA-based signature to more accurately predict the prognosis of different PCa patients, so as to improve patient management and prognosis.<h4>Methods</h4>Through univariate and multivariate Cox regression analysis, this study constructed a 4 lncRNAs-based prognosis nomogram for the classification and prediction of survival risk in patients with PCa based on TCGA data. Then we used the data of TCGA and ICGC to verify the performance of our prediction model. The receiver operating characteristic curve was plotted for detecting and validating our prediction model sensitivity and specificity. In addition, Cox regression analysis was conducted to examine whether the signature's prediction ability was independent of additional clinicopathological variables. Possible biological functions for those prognostic lncRNAs were predicted on those 4 protein-coding genes (PCGs) related to lncRNAs.<h4>Results</h4>Four lncRNAs (HOXB-AS3, YEATS2-AS1, LINC01679, PRRT3-AS1) were extracted after COX regression analysis for classifying patients into high and low-risk groups by different OS rates. As suggested by ROC analysis, our proposed model showed high sensitivity and specificity. Independent prognostic capability of the model from other clinicopathological factors was indicated through further analysis. Based on functional enrichment, those action sites for prognostic lncRNAs were mostly located in the extracellular matrix and cell membrane, and their functions are mainly associated with the adhesion, activation and transport of the components across the extracellular matrix or cell membrane.<h4>Conclusion</h4>Our current study successfully identifies a novel candidate, which can provide more convincing evidence for prognosis in addition to the traditional clinicopathological indicators to predict the PCa survival, and laying the foundation for offering potentially novel therapeutic treatment. Additionally, this study sheds more lights on the PCa-related molecular mechanisms.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249951&type=printable
spellingShingle Peng Zhang
Xiaodong Tan
Daoqiang Zhang
Qi Gong
Xuefeng Zhang
Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
PLoS ONE
title Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
title_full Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
title_fullStr Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
title_full_unstemmed Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
title_short Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
title_sort development and validation of a set of novel and robust 4 lncrna based nomogram predicting prostate cancer survival by bioinformatics analysis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249951&type=printable
work_keys_str_mv AT pengzhang developmentandvalidationofasetofnovelandrobust4lncrnabasednomogrampredictingprostatecancersurvivalbybioinformaticsanalysis
AT xiaodongtan developmentandvalidationofasetofnovelandrobust4lncrnabasednomogrampredictingprostatecancersurvivalbybioinformaticsanalysis
AT daoqiangzhang developmentandvalidationofasetofnovelandrobust4lncrnabasednomogrampredictingprostatecancersurvivalbybioinformaticsanalysis
AT qigong developmentandvalidationofasetofnovelandrobust4lncrnabasednomogrampredictingprostatecancersurvivalbybioinformaticsanalysis
AT xuefengzhang developmentandvalidationofasetofnovelandrobust4lncrnabasednomogrampredictingprostatecancersurvivalbybioinformaticsanalysis